resTORbio

resTORbio

A biopharmaceutical company developing therapeutics for treating age-related diseases.

resTORbio is a biopharmaceutical company developing therapeutics for treating age-related diseases that is headquartered in Boston, Massachusetts and was founded in 2016 by Chen Schor and Joan Mannick.

Funding

Series A

On January 1, 2017 resTORbio completed their series A funding round with $25 million in funding from PureTech Health.

Series B

On November 30, 2017 resTORbio completed their series B funding rounds with $40 million in funding from OrbiMed (lead investor), Rock Springs Capital, Recharge Capital, Quan Capital, Nest.Bio Ventures, and Fidelity Management and Research Company.

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
resTORbio Series A Funding Round January 2017
25,000,000
2 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Chen Schor

Co-Founder, President and CEO

Joan Mannick

Co-Founder, Chief Medical Officer

Sarb Shergill

Vice President of Clinical Operations

Further reading

Title
Author
Link
Type
Date

resTORbio launches Phase Ib/IIa trial of RTB101 to treat Parkinson's

Drugdevelopment-technology

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.